Title Credit Type Event datesort descending Cost
Networks in Neurology: New Agents and Strategies for Migraine (Credit Expired) Enduring $0.00
Evolution of Progression: An Expert Forum on Advancements in Monitoring and Treating Multiple Sclerosis (Credit Expired) Enduring $0.00
Unlocking the Alzheimer’s Brain: How Radiological Tools and Biomarkers Hold the Key to Early Diagnosis and Decision-Making
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Attendance
 Enduring $0.00
Out of the Dark, Into the Light: Illuminating Modern Strategies for the Detection and Treatment of Bipolar Depression (Credit Expired) Enduring $0.00
Individualizing Narcolepsy: Using Clinical Evidence and Patient Factors to Improve Diagnosis and Optimize Therapeutic Management
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Attendance
 Enduring $0.00
Module 2: Initiation and Selection of Disease Modifying Therapy Enduring $0.00
Finding Something in Nothing: Patient-Centered Approaches to Resolve Emotional Blunting in Major Depressive Disorder (Credit Expired) Enduring $0.00
Broadening the Treatment Horizon: Examining the Expanding Roles of New Therapies in Epilepsy Management (Credit Expired) Enduring $0.00
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) --... Enduring $0.00
Networks in Neurology: Insights From a Collaborative CME Experience With Practicing Clinicians Regarding New Agents and Strategies for Multiple... Enduring $0.00
Across the Spectrum: Transforming the Detection and Management of Disease State Transitions Across the Spectrum of Multiple Sclerosis (Credit Expired) Enduring $0.00
Navigating the Clinic: Applying Modern Evidence, Expert Insights, and Practice Simulations to Optimize Idiopathic Hypersomnia Management Enduring $0.00
Multiple Sclerosis Management: Shedding Light on the Patient Perspective (Credit Expired) Enduring $0.00
Part 3: Evolving Roles in Alzheimer’s Disease Management: Team-Based Care in the Modern Age of Disease-Modifying Therapy Enduring $0.00
The Path to Least Resistance: The Emerging Role of Noncovalent BTK Inhibitors in CLL/SLL Across Clinical Practice Settings
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 AAPA Category I CME
 Enduring $0.00

Pages